Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Net Income towards Common Stockholders: 2018-2025

Historic Net Income towards Common Stockholders for Arcturus Therapeutics Holdings (ARCT) over the last 8 years, with Sep 2025 value amounting to -$13.4 million.

  • Arcturus Therapeutics Holdings' Net Income towards Common Stockholders fell 94.81% to -$13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.7 million, marking a year-over-year decrease of 6.57%. This contributed to the annual value of -$80.9 million for FY2024, which is 172.30% down from last year.
  • Arcturus Therapeutics Holdings' Net Income towards Common Stockholders amounted to -$13.4 million in Q3 2025, which was down 46.49% from -$9.2 million recorded in Q2 2025.
  • Arcturus Therapeutics Holdings' 5-year Net Income towards Common Stockholders high stood at $118.6 million for Q4 2022, and its period low was -$57.7 million during Q1 2021.
  • In the last 3 years, Arcturus Therapeutics Holdings' Net Income towards Common Stockholders had a median value of -$14.1 million in 2025 and averaged -$13.4 million.
  • As far as peak fluctuations go, Arcturus Therapeutics Holdings' Net Income towards Common Stockholders tumbled by 509.45% in 2021, and later skyrocketed by 415.16% in 2022.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Net Income towards Common Stockholders (Quarterly) stood at -$37.6 million in 2021, then soared by 415.16% to $118.6 million in 2022, then tumbled by 109.84% to -$11.7 million in 2023, then tumbled by 156.89% to -$30.0 million in 2024, then slumped by 94.81% to -$13.4 million in 2025.
  • Its Net Income towards Common Stockholders was -$13.4 million in Q3 2025, compared to -$9.2 million in Q2 2025 and -$14.1 million in Q1 2025.